Yiru Long

4PUBLICATIONS
18CO-AUTHORS
Medical devicesMolecular targetsInnate immunityAgricultural molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 24, 2026
Lipid metabolic reprogramming of macrophage by host APOBEC3 deficiency enhances anti-tumor immunity.

|Dec 09, 2022
Suppression of Tumor or Host Intrinsic CMTM6 Drives Antitumor Cytotoxicity in a PD-L1-Independent Manner.

Yiru Long, Runqiu Chen, Xiaolu Yu

|Oct 17, 2022
PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way.

Xiaolu Yu, Yiru Long, Binfan Chen

|Feb 01, 2022
CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity.

Yiru Long, Jianhua Sun, Tian-Zhang Song

Pageof 1

Frequent Collaborators

2 joint publications

Likun Gong

2 joint publications

Fanglin Li

1 joint publications

Weiliang Zhu

1 joint publications

Jianqing Xu